The Alzheimer Society Research Program – Proof of Concept Grants- LOI
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire within unit
Memorial Deadline: RIS review not required for LOI
External Deadline: Monday 17th, July 2023
Description
Together with the Alzheimer Society of Canada, Brain Canada is pleased to announce the letter of intent (LOI) stage of the Proof of Concept Grants as part of the 2023 Alzheimer Society Research Program (ASRP). The ASRP provides grants and awards to support Canadian research that promises new insights into causes, prevention, diagnosis, treatment, and management of Alzheimer’s disease and other dementias.
The Proof of Concept Grants are designed to fund innovative, high-risk, and high-reward research that pushes beyond the boundaries of our existing understanding of dementia. Interested researchers must first submit a LOI in order to be deemed eligible, prior to being invited to submit a full application.
This funding opportunity is open to dementia researchers in Canada with new or unique hypotheses. Successful applicants can receive up to $100,000 over three years to conduct exploratory research that will positively impact the lives of people living with dementia and their caregivers.
Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.
Click here to submit a Letter of Intent.
Click here to view the Proof of Concept LOI guidelines.
Successful applicants will be invited to complete a full application later this year.
Deadline to complete your Letter of Intent: July 17, 2023 at 5 p.m. ET
Should you have any questions, please contact research@alzheimer.ca.
This program has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) Brain Canada Foundation, and Alzheimer Society of Canada.